A case study of nutrient intervention of oral precancerous lesions in India.
Tobacco chewing and/or smoking are strongly related to several cancers, mainly of the upper aerodigestive tract. Several studies on diet and cancer links suggest that micronutrients, particularly antioxidant vitamins and minerals, are risk modifiers of cancers of epithelial origin. This study looks at the impact of micronutrients such as vitamin A, riboflavin, zinc and selenium as intervention agents in subjects with and without precancerous lesions in a high risk group (reverse smokers of chutta-rolled tobacco leaf). Reverse smokers from four villages were enrolled in the study. 150 subjects were supplemented with four nutrients, namely vitamin A, riboflavin, zinc and selenium in the form of a capsule twice a week for 1 year. 148 controls received a placebo capsule containing lactose for the same period. Clinical history and anthropometric data were collected from all the subjects and a clinical photograph of the palate was taken. Micronutrients were estimated in random blood collected from a sub-sample before and after the study. Micronutrients improved the vitamin A, riboflavin and selenium nutriture in the supplemented group with a concomittant regression of precancerous lesions present on the palate. Clinically complete remission of white, red and combination lesions was seen in 57% of subjects on supplements whereas 8% on placebo showed a positive response. Further progression of these lesions was seen in 10% of the supplemented group compared with 47% in the placebo group (P < 0.001). In the non-lesion group, new lesions appeared in 12% on supplements while more than 38% on the placebo developed new lesions (P < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
Krishnaswamy
K
K
National Institute of Nutrition, Hyderabad, India.
Prasad
M P
MP
Krishna
T P
TP
Annapurna
V V
VV
Reddy
G A
GA
D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000628:therapy*; D011230:Precancerous Conditions / Q000628:therapy*; D012256:Riboflavin / Q000627:therapeutic use; D012643:Selenium / Q000627:therapeutic use; D012907:Smoking / Q000009:adverse effects; D014131:Trace Elements / Q000627:therapeutic use*; D014801:Vitamin A / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D014131:Trace Elements; D014801:Vitamin A; D012643:Selenium; D015032:Zinc; D012256:Riboflavin